NALCN‐mediated sodium influx confers metastatic prostate cancer cell invasiveness
The EMBO Journal · 03.07.2023 · 42 (13)
DOI: 10.15252/embj.2022112198 ↗Kurz gefasst
Fachartikel in der Zeitschrift The EMBO Journal, online erschienen am 06.06.2023. Verfasst von Antoine Folcher und 33 weiteren Autor:innen. Beteiligte Einrichtung: Inserm U1003, Laboratory of Excellence, Ion Channels Science and Therapeutics, Equipe Labellisée par la Ligue Nationale Contre le Cancer, GIS ONCO Li…. Hauptthemen laut MEDLINE: Sodium, Prostatic Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Institute for Cancer Research, Ligue Nationale Contre Le Cancer, CPER Cancer.
Abstract (Originalsprache)
There is growing evidence that ion channels are critically involved in cancer cell invasiveness and metastasis. However, the molecular mechanisms of ion signaling promoting cancer behavior are poorly understood and the complexity of the underlying remodeling during metastasis remains to be explored. Here, using a variety of in vitro and in vivo techniques, we show that metastatic prostate cancer cells acquire a specific Na+ /Ca2+ signature required for persistent invasion. We identify the Na+ leak channel, NALCN, which is overexpressed in metastatic prostate cancer, as a major initiator and regulator of Ca2+ oscillations required for invadopodia formation. Indeed, NALCN-mediated Na+ influx into cancer cells maintains intracellular Ca2+ oscillations via a specific chain of ion transport proteins including plasmalemmal and mitochondrial Na+ /Ca2+ exchangers, SERCA and store-operated channels. This signaling cascade promotes activity of the NACLN-colocalized proto-oncogene Src kinase, actin remodeling and secretion of proteolytic enzymes, thus increasing cancer cell invasive potential and metastatic lesions in vivo. Overall, our findings provide new insights into an ion signaling pathway specific for metastatic cells where NALCN acts as persistent invasion controller.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Inserm U1003, Laboratory of Excellence, Ion Channels Science and Therapeutics, Equipe Labellisée par la Ligue Nationale Contre le Cancer, GIS ONCO Lille, University of Lille, Lille, France.
- TISBio, Unité de Glycobiologie Structurale et Fonctionnelle (UGSF), CNRS, UMR 8576, Université de Lille, Lille, France.
- Cell Physiology Research Group, Department of Physiology, University of Extremadura, Cáceres, Spain.
- Cancéropôle du Grand Ouest, Plateforme In Vivo, Nantes, France.
- Inserm UMR1069, Nutrition Croissance et Cancer, University of Tours, Tours, France.
- Univ Lyon, Université Claude Bernard Lyon 1, Inserm UMR 1033 LYOS, Lyon, France.
ORCID-Profile: Antoine Folcher, Dmitri Gordienko, Oksana Iamshanova, Alexandre Bokhobza, Lucie Brisson, V'yacheslav Lehen'kyi, Stéphanie Chadet, Julien Sobilo, Giulia Villari, Guido Serini, Sébastien Roger, Mustafa Djamgoz, Natalia Prevarskaya
Förderung
- Institute for Cancer Research
- Ligue Nationale Contre Le Cancer
- CPER Cancer
- FEDER Région Hauts‐de‐France
Zitieren
APA
Folcher, A., Gordienko, D., Iamshanova, O., Bokhobza, A., Shapovalov, G., Kannancheri-Puthooru, D., Mariot, P., Allart, L., Desruelles, E., Spriet, C., Diez, R., Oullier, T., Marionneau-Lambot, S., Brisson, L., Geraci, S., Impheng, H., Lehen'kyi, V., Haustrate, A., Mihalache, A., …, & Prevarskaya, N. (2023). NALCN‐mediated sodium influx confers metastatic prostate cancer cell invasiveness. The EMBO Journal, 42(13). https://doi.org/10.15252/embj.2022112198
Vancouver
Folcher A, Gordienko D, Iamshanova O, Bokhobza A, Shapovalov G, Kannancheri-Puthooru D, et al. NALCN‐mediated sodium influx confers metastatic prostate cancer cell invasiveness. The EMBO Journal. 2023;42(13). doi:10.15252/embj.2022112198
BibTeX
@article{Folcher2023,
author = {Folcher, Antoine and Gordienko, Dmitri and Iamshanova, Oksana and Bokhobza, Alexandre and Shapovalov, George and Kannancheri-Puthooru, Dheeraj and Mariot, Pascal and Allart, Laurent and Desruelles, Emilie and Spriet, Corentin and Diez, Raquel and Oullier, Thibauld and Marionneau-Lambot, Séverine and Brisson, Lucie and Geraci, Sandra and Impheng, Hathaichanok and Lehen'kyi, V'yacheslav and Haustrate, Aurélien and Mihalache, Adriana and Gosset, Pierre and Chadet, Stéphanie and Retif, Stéphanie and Laube, Maryline and Sobilo, Julien and Lerondel, Stéphanie and Villari, Giulia and Serini, Guido and Pla, Alessandra Fiorio and Roger, Sébastien and Fromont-Hankard, Gaelle and Djamgoz, Mustafa and Clezardin, Philippe and Monteil, Arnaud and Prevarskaya, Natalia},
title = {NALCN‐mediated sodium influx confers metastatic prostate cancer cell invasiveness},
journal = {The EMBO Journal},
year = {2023},
volume = {42},
number = {13},
doi = {10.15252/embj.2022112198}
}
EUVIMED